Authors:
HARSCH M
GEBHARDT A
REYMANN A
LANG G
SCHLIACK M
LOSER R
BRAESEN JH
NIENDORF A
Citation: M. Harsch et al., EFFECTS OF PRAVASTATIN ON CHOLESTEROL-METABOLISM OF CHOLESTEROL-FED HETEROZYGOUS WHHL RABBITS, British Journal of Pharmacology, 124(2), 1998, pp. 277-282
Authors:
SEIDEL A
HASMANN M
LOSER R
BUNGE A
SCHAEFER B
HERZIG I
STEIDTMANN K
DIETEL M
Citation: A. Seidel et al., INTRACELLULAR-LOCALIZATION, VESICULAR ACCUMULATION AND KINETICS OF DAUNORUBICIN IN SENSITIVE AND MULTIDRUG-RESISTANT GASTRIC-CARCINOMA EPG85-257 CELLS, Virchows Archiv, 426(3), 1995, pp. 249-256
Authors:
SCHARNAGL H
MARZ W
SCHLIACK M
LOSER R
GROSS W
Citation: H. Scharnagl et al., A NOVEL ASSAY FOR CYTOSOLIC 3-HYDROXY-3-METHYGLUTARYL-COENZYME-A SYNTHASE ACTIVITY USING REVERSED-PHASE ION-PAIR CHROMATOGRAPHY - DEMONSTRATION THAT LIFIBROL (K12.148) MODULATES THE ENZYME-ACTIVITY, Journal of lipid research, 36(3), 1995, pp. 622-627
Authors:
KIRCHGESSNER M
SCHLIACK M
SPAULDING G
EDER K
LOSER R
SEIBEL K
ERHARDT W
ASCHERL R
Citation: M. Kirchgessner et al., THE EFFECT OF THE HYPOLIPIDEMIC COMPOUND LIFIBROL ON BILE-FLOW, BILE LIPIDS AND THE LITHOGENIC INDEX OF BILE IN PIGS, Journal of animal physiology and animal nutrition, 71(4-5), 1994, pp. 261-267
Authors:
KIRCHGESSNER M
SCHLIACK M
SPAULDING G
LOSER R
SEIBEL K
EDER K
ERHARDT W
ASCHERL R
Citation: M. Kirchgessner et al., INFLUENCE OF THE HYPOCHOLESTEROLEMIC COMPOUND LIFIBROL ON SERUM-LIPIDS AND ON PARAMETERS OF CLINICAL-CHEMISTRY AND HEMATOLOGY OF PIGS, Journal of animal physiology and animal nutrition, 71(4-5), 1994, pp. 268-276
Citation: E. Biedermann et al., DROLOXIFENE INHIBITS GROWTH AND PROTEIN-S YNTHESIS OF BREAST-CANCER CELLS MORE EFFECTIVELY THAN TAMOXIFEN AND TOREMIFEN, Onkologie, 17, 1994, pp. 17-21
Authors:
KUNG W
WOSIKOWSKI K
HASMANN M
LOSER R
EPPENBERGER U
Citation: W. Kung et al., INHIBITION OF GROWTH-FACTOR INDUCED PROLI FERATION OF MCF-7 BREAST-CANCER CELLS WITH ANTIESTROGENS AND EFFECTS ON PROTO-ONCOGEN ACTIVATION, Onkologie, 17, 1994, pp. 27-31